Variation in Total Cholesterol, Triglycerides Linked to Alzheimer Disease Risk
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, July 6, 2023 -- Variability in total cholesterol and triglycerides is associated with an increased risk for incident Alzheimer disease and Alzheimer disease-related dementias (AD/ADRD), according to a study published online July 5 in Neurology.
Ethan D. Moser, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the variation of multiple lipid types and their association with the development of AD/ADRD in a large geographically defined population-based cohort of residents living in Olmsted County, Minnesota, aged 60 years on the index date (Jan. 1, 2006). Participants with three or more lipid measurements in the five years prior to the index date were included; lipid variation was measured using variability independent of the mean.
The final analysis included 11,571 participants who were followed for a median of 12.9 years. The researchers identified 2,473 incident AD/ADRD cases during follow-up. Participants in the highest quintile of total cholesterol variability had a 19 percent increased risk for AD/ADRD, and those in the highest quintile of triglycerides variability had a 23 percent increased risk after adjustment for multiple confounding variables, including sex, race, baseline lipid measurements, education, body mass index, and lipid-lowering treatment.
"It remains unclear why and how fluctuating levels of cholesterol and triglycerides are related to the risk of Alzheimer's disease," a coauthor said in a statement. "Further studies looking at the changes over time for this relationship are needed in order to confirm our results and potentially consider preventative strategies."
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181
MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...
Cognitive Impairment Delayed With Genetic Variant
THURSDAY, June 20, 2024 -- Cognitive impairment is delayed among persons who are heterozygous for the apolipoprotein E3 Christchurch variant (APOE3Ch), according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.